Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study
This inaugural multicenter study introduces a novel algorithm for detecting and treating sole reciprocal fusions in advanced cancers, expanding the patient population potentially amenable to KIs.
Authors
- Zhengchuang Liu
- Hou‐Quan Tao (ORCID: https://orcid.org/0000-0002-0609-9203)
- Tonghui Ma (ORCID: https://orcid.org/0000-0002-5414-0522)
- Zai‐yuan Ye (ORCID: https://orcid.org/0009-0001-9233-9663)
- Chunyang Wang (ORCID: https://orcid.org/0000-0002-6707-2274)
- Jiao Feng (ORCID: https://orcid.org/0000-0001-6128-851X)
- Baoming Wang (ORCID: https://orcid.org/0000-0002-8701-3896)
- Qian Liu (ORCID: https://orcid.org/0000-0001-5341-1290)
Institutions
- Hangzhou Normal University (CN)
- Zhejiang Provincial People's Hospital (CN)
- Hangzhou DAC Biotech (China) (CN)
- Zhejiang Medicine (China) (CN)
- Hangzhou Medical College (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1002/cam4.70191
- Citations
- 3
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.86